Ocugen, Inc. (OCGN)
1.025
0.00 (0.00%)
USD |
NASDAQ |
Sep 14, 11:49
Ocugen Market Cap : 347.52M for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 345.83M |
| September 10, 2026 | 347.52M |
| September 09, 2026 | 361.08M |
| September 08, 2026 | 450.93M |
| September 04, 2026 | 461.10M |
| September 03, 2026 | 457.71M |
| September 02, 2026 | 447.54M |
| September 01, 2026 | 450.93M |
| August 31, 2026 | 450.93M |
| August 28, 2026 | 447.54M |
| August 27, 2026 | 464.49M |
| August 26, 2026 | 478.05M |
| August 25, 2026 | 474.66M |
| August 24, 2026 | 461.10M |
| August 21, 2026 | 471.27M |
| August 20, 2026 | 471.27M |
| August 19, 2026 | 501.79M |
| August 18, 2026 | 454.32M |
| August 17, 2026 | 466.19M |
| August 14, 2026 | 457.71M |
| August 13, 2026 | 457.71M |
| August 12, 2026 | 474.66M |
| August 11, 2026 | 464.49M |
| August 10, 2026 | 444.15M |
| August 07, 2026 | 433.98M |
| Date | Value |
|---|---|
| August 06, 2026 | 420.42M |
| August 05, 2026 | 433.98M |
| August 04, 2026 | 444.15M |
| August 03, 2026 | 423.75M |
| July 31, 2026 | 416.13M |
| July 30, 2026 | 426.28M |
| July 29, 2026 | 402.60M |
| July 28, 2026 | 419.52M |
| July 27, 2026 | 426.28M |
| July 24, 2026 | 409.37M |
| July 23, 2026 | 429.66M |
| July 22, 2026 | 436.43M |
| July 21, 2026 | 439.81M |
| July 20, 2026 | 449.96M |
| July 17, 2026 | 460.11M |
| July 16, 2026 | 463.50M |
| July 15, 2026 | 483.80M |
| July 14, 2026 | 483.80M |
| July 13, 2026 | 477.03M |
| July 10, 2026 | 497.33M |
| July 09, 2026 | 497.33M |
| July 08, 2026 | 507.48M |
| July 07, 2026 | 507.48M |
| July 06, 2026 | 504.10M |
| July 02, 2026 | 510.86M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.790B |
| Anika Therapeutics, Inc. | 279.97M |
| Gilead Sciences, Inc. | 180.94B |
| MannKind Corp. | 1.165B |
| Vertex Pharmaceuticals, Inc. | 131.68B |
Market Cap Related Metrics
| PS Ratio | 71.76 |
| PEG Ratio | -0.1387 |
| Price | 1.025 |
| Earnings Yield | -24.85% |
| PEGY Ratio | -0.1387 |